XML 110 R91.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stockholders’ (Deficit) Equity - Co-Founder Grants (Details)
shares in Millions, $ in Millions
1 Months Ended 3 Months Ended 12 Months Ended
Dec. 31, 2017
tranche
shares
Dec. 31, 2021
shares
Dec. 31, 2023
USD ($)
shares
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Allocated share-based compensation expense | $     $ 338.0 $ 330.7 $ 287.1
Restricted Stock          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Shares granted (in shares)     22.2   27.8
Vesting period     4 years    
Awards vesting (in shares)     0.0    
Co-Founder Grant | Restricted Stock          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Expiration period 10 years        
Number of tranches | tranche 9        
Trading period 30 days        
Allocated share-based compensation expense | $     $ 9.4 $ 11.7  
Remaining unamortized stock-based compensation | $     $ 2.4    
Co-Founder Grant | Restricted Stock | Tranche One          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting period 4 years        
Co-Founder Grant | Restricted Stock | Tranche One | Maximum          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Percentage vested maximum 20.00%        
Co-Founder Grant | Chief Executive Officer | Restricted Stock          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Shares granted (in shares) 10.3        
Awards vesting (in shares)   2.1